日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer

细胞特异性纳米工程策略破坏髓系来源抑制细胞的耐受性信号传导,增强胰腺癌的抗肿瘤免疫力

Deshpande, Nilesh U; Bianchi, Anna; Amirian, Haleh; De Castro Silva, Iago; Rafie, Christine I; Surnar, Bapurao; Rajkumar, Karthik; Ashokan, Akash; Ogobuiro, Ifeanyichukwu C; Patel, Manan; Stelekati, Erietta; Dhar, Shanta; Datta, Jashodeep

Heterogeneity of type 2 diabetes in rural India

印度农村地区2型糖尿病的异质性

Patil, Suvarna; Patil, Ajay; Tare, Kaustubh; Bhat, Pallavi; Kumbhar, Akash; Mulay, Datta; Jadhav, Dnyaneshwar; Methi, Vaibhav; Surnar, Sachin; Humbare, Tushar; Khaladkar, Aniket; Deosale, Shreyansh; Joglekar, Charudatta

Simultaneous targeting of peripheral and brain tumors with a therapeutic nanoparticle to disrupt metabolic adaptability at both sites

利用治疗性纳米颗粒同时靶向外周和脑肿瘤,以破坏这两个部位的代谢适应性。

Ashokan, Akash; Sarkar, Shrita; Kamran, Mohammad Z; Surnar, Bapurao; Kalathil, Akil A; Spencer, Alexis; Dhar, Shanta

New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance

顺铂前药利用代谢底物偏好性克服癌症固有耐药性的新途径

Kalathil, Akil A; Guin, Subham; Ashokan, Akash; Basu, Uttara; Surnar, Bapurao; Delma, Katiana S; Lima, Leonor M; Kryvenko, Oleksandr N; Dhar, Shanta

Correction to "New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance"

对“顺铂前药利用代谢底物偏好克服癌症固有耐药性的新途径”的更正

Kalathil, Akil A; Guin, Subham; Ashokan, Akash; Basu, Uttara; Surnar, Bapurao; Delma, Katiana S; Lima, Leonor M; Kryvenko, Oleksandr N; Dhar, Shanta

All-in-One Pyruvate Dehydrogenase Kinase Inhibitor for Tracking, Targeting, and Enhanced Efficacy

用于追踪、靶向和增强疗效的全效丙酮酸脱氢酶激酶抑制剂

Zhang, Xiao; Sarkar, Shrita; Ashokan, Akash; Surnar, Bapurao; Kolishetti, Nagesh; Dhar, Shanta

Intersection of Inorganic Chemistry and Nanotechnology for the Creation of New Cancer Therapies

无机化学与纳米技术的交叉融合在新型癌症疗法的开发中

Shah, Anuj S; Surnar, Bapurao; Kolishetti, Nagesh; Dhar, Shanta

Controlled release nanoplatforms for three commonly used chemotherapeutics

用于三种常用化疗药物的控释纳米平台

Costoya, Joel; Surnar, Bapurao; Kalathil, Akil A; Kolishetti, Nagesh; Dhar, Shanta

Biomaterial-targeted precision nanoparticle delivery to the injured spinal cord

生物材料靶向精准纳米颗粒递送至受损脊髓

Ciciriello, Andrew J; Surnar, Bapurao; Medy, Giovanni D; Su, Xiaoyu; Dhar, Shanta; Dumont, Courtney M

Transformation of Amphiphilic Antiviral Drugs into New Dimensional Nanovesicles Structures

将两亲性抗病毒药物转化为新型纳米囊泡结构

Hamdan, Suzana; Surnar, Bapurao; Kafkoutsou, Alexia L; Magurno, Luciano; Deo, Sapna K; Jayaweera, Dushyantha T; Dhar, Shanta; Daunert, Sylvia